Abstract
Starting from a high throughput screening hit, a series of 3,4-dihydro-2H-benzoxazinones has been identified with both high affinity for the 5-HT(1A) receptor and potent 5-HT reuptake inhibitory activity. The 5-(2-methyl)quinolinyloxy derivative combined high 5-HT(1A/1B/1D) receptor affinities with low intrinsic activity and potent inhibition of the 5-HT reuptake site (pK(i)8.2). This compound also had good oral bioavailability and brain penetration in the rat.
MeSH terms
-
Animals
-
Benzoxazines / chemical synthesis*
-
Benzoxazines / pharmacology
-
Biological Availability
-
Brain / metabolism
-
Cell Line
-
Drug Stability
-
Humans
-
Radioligand Assay
-
Rats
-
Selective Serotonin Reuptake Inhibitors / chemical synthesis*
-
Selective Serotonin Reuptake Inhibitors / pharmacology
-
Serotonin 5-HT1 Receptor Antagonists*
-
Structure-Activity Relationship
-
Synaptosomes / metabolism
Substances
-
Benzoxazines
-
Serotonin 5-HT1 Receptor Antagonists
-
Serotonin Uptake Inhibitors